Markus Siegers

Vorstand/ GeschäFtsfüHrender Gesellschafter

Nosconte AG · Berlin

Present

Ceo

Nosconte AG · Berlin und Umgebung, Deutschland

Present

Our dedication is to enhance the effciency of information gathering, presentation and retrieval by at least one order of magnitude compared to existing software solutions. Our disruptive approach includes an innovative data format, groundbreaking possi-bilities to structure data and extensive features to collaboratively work in groups with said data.

Member of the Supervisory Board + Consultant

Biogents AG · Regensburg

Managing Partner

Biogents AG · Regensburg

• developing the business case, writing the business plan, establishing contacts to potential investors, acquiring the funding of the company (€ 700k in equity from several business angel and € 300k as a loan from Commerzbank AG, a major German bank) at favorable conditions during a rather challenging time for companies (financial crisis); • working with scientific opinion leaders in the US e.g. from the USDA; initiating contacts to the former president of the American Mosquito Control Association and to two leading mosquito control groups and initiating scientific studies under their supervision; • establishment and supervision of a strategic partnership with Linde AG: on-site supply of 4-10kg carbon dioxide cylinders for Biogents (private) customers in Germany and Italy • acquisition and supervision of CFG (Biogents’ major sales partner for the retail market serving almost every major DIY Chain in Italy including Leroy Merlin, Obi, Brico Io etc.) and smaller sales partners in Germany…

Interim Manager/ Consultant

Various start-up and expansion stage companies from Germany, USA, Australia · Munich

• market analysis by primary and secondary market research: describing and evaluating market structures and dynamics, analysing applied treatments and clinical paths, analysing competitors (including their route to the market), describing relevant regulatory agencies as well as current and future reimbursement policies, estimating costs of current treatments to the healthcare system • establishing contacts to opinion leaders as well as to other key players (insurance companies, regulatory agencies etc.) for the relevant indications of two new medical devices • narrowing down and validating the agreed market entry strategy, companies: Enterix (colorectal cancer diagnostic; www.insuretest.com), Neuromonix (medical device; www.neuromonics.com) • identifying and contacting potential customers, working on acquired projects, companies: Puretech Development (consultancy; now: www.puretechventures.com), to some extend also for RNAx (si-RNA) • coaching entrepreneurs: guiding the processes of se…

Associate

MPM Capital · Munich

• preparing contracts • participating in due diligence processes • analyzing business plans • sourcing investment cases/ establishing contacts to biotech companies

Provisional Head of Technology (Life Sciences; Promotion to Project Manager/ Commercial Power of Att

IKB Private Equity GmbH · Düsseldorf

• monitoring portfolio companies and participating in BoD meetings • proposing investments to the management board of the parent company IKB Deutsche Industriebank AG • negotiating contracts • valuating biotech companies • accomplishing due diligences • establishing an international network of medical and scientific experts (incl. NIH in the US) as well as to innovation centres in the US and Europe • identifying top research hubs and key scientists for certain indications and medical applications • setting up a knowledge pool • analyzing business plans • sourcing investment cases/ establishing contacts to biotech companies • special training in financial statement analysis and company law

Analyst

IKB Deutsche Industriebank AG